| Application no. and date | 21153302.1 (espacenet) (Federated) (European Patent Register), 20161028 | | Patent/reg. no. and date | DK/EP 3875459, 20231213 | | Publication date | 20210908 | | Priority no. and date | US 201562249074 P, 20151030 | | EP pub. no. and date |
EP 3875459 20210908 | | Effective date | | | Applicant/owner | Neurocrine Biosciences, Inc., 12780 El Camino Real
San Diego, California 92130, US | | Applicant ref. no. | V470017DK00 | | Inventor | MCGEE, Kevin, 82663 Marlow Road
Eugene, Oregon 97405, US,
ZOOK, Scott, 3716 Arizona Street
San Diego, California 92104, US,
CARR, Andrew, 91 Lancaster Gate
Upper Cambourne
Cambridge, CB23 6AU, GB,
BONNAUD, Thierry, 17 Sunmead Walk
Cambridge, CB1 9YB, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4375 (2006.01) , A61P 25/00 (2006.01) , A61P 25/14 (2006.01) , C07D 471/04 (2006.01) | | Title | Valbenazin-dihydrochloridsalte og polymorfe deraf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
